$0.860000
0.044.65%
At Close: -
$0.864000
0.00400.47%
After Hours: 4:26 PM EDT
15 minutes delayed
CytoSorbents
CTSONASDAQ
CytoSorbents (NASDAQ:CTSO) Stock, Analyst Ratings, Price Targets, Predictions
CytoSorbents Corp has a consensus price target of $2.67, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, HC Wainwright & Co., and HC Wainwright & Co. on May 15, 2024, May 7, 2024, and March 15, 2024. With an average price target of $1.67 between B. Riley Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 92.90% upside for CytoSorbents Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
B. Riley Securities
HC Wainwright & Co.
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for CytoSorbents
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 247.22% | B. Riley Securities | Yuan Zhi | → $3 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 15.74% | HC Wainwright & Co. | Sean Lee | → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 03/15/2024 | Buy Now | 15.74% | HC Wainwright & Co. | Sean Lee | → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 12/29/2023 | Buy Now | 15.74% | HC Wainwright & Co. | Sean Lee | $5.5 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 09/07/2023 | Buy Now | 362.96% | B. Riley Securities | Justin Walsh | → $4 | Reinstates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 536.57% | HC Wainwright & Co. | Sean Lee | → $5.5 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | Buy Now | 536.57% | HC Wainwright & Co. | Sean Lee | → $5.5 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | Buy Now | 536.57% | HC Wainwright & Co. | Sean Lee | → $5.5 | Reiterates | → Buy | Get Alert |
| 11/04/2022 | Buy Now | 536.57% | HC Wainwright & Co. | Sean Lee | $9 → $5.5 | Maintains | Buy | Get Alert |
| 05/04/2022 | Buy Now | 594.44% | B. Riley Securities | Justin Walsh | $7 → $6 | Maintains | Buy | Get Alert |
| 05/04/2022 | Buy Now | 941.67% | HC Wainwright & Co. | Sean Lee | $13 → $9 | Maintains | Buy | Get Alert |
FAQ
What is the target price for CytoSorbents (CTSO) stock?
The latest price target for CytoSorbents (NASDAQ:CTSO) was reported by B. Riley Securities on May 15, 2024. The analyst firm set a price target for $3.00 expecting CTSO to rise to within 12 months (a possible 247.22% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CytoSorbents (CTSO)?
The latest analyst rating for CytoSorbents (NASDAQ:CTSO) was provided by B. Riley Securities, and CytoSorbents reiterated their buy rating.
When was the last upgrade for CytoSorbents (CTSO)?
There is no last upgrade for CytoSorbents
When was the last downgrade for CytoSorbents (CTSO)?
The last downgrade for CytoSorbents Corp happened on December 29, 2023 when HC Wainwright & Co. changed their price target from $5.5 to $1 for CytoSorbents Corp.
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating CytoSorbents (CTSO) correct?
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a reiterated with a price target of $0.00 to $3.00. The current price CytoSorbents (CTSO) is trading at is $0.86, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.